robert henric

robert henric

Followers 21
Following 20
The study involved four major activities in estimating the current market size for synthetic stem cells.The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.Secondary Research:In the secondary research process, various secondary sources such as Hoovers, Bloomberg Business Week, Forbes, and Dun & Bradstreet were referred to, to identify and collect information useful for this technical, market-oriented, and commercial study of the synthetic stem cells industry.These secondary sources included annual reports, press releases & investor presentations of companies; white papers; certified publications; articles by recognized authors; gold standard & silver standard websites; food safety organizations; regulatory bodies; trade directories; and databases.Secondary research was mainly used to obtain key information about the industry’s supply chain, the total pool of key players, market classification, and segmentation, according to the industry trends to the bottom-most level and regional markets.According to the new market research report “Synthetic Stem Cells Market by Application (Cardiovascular Disease, Neurological Disorders, Other Applications (Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorders)), Region (North America (US, Canada), Europe, APAC, RoW) – Global Forecast to 2028″ published by MarketsandMarkets™, the artificial stem cells market is expected to grow from USD 14 million in 2023 to USD 37 million by 2028, at a CAGR of 22.5% during the forecast periodRequest Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=4959435Geographically; North America is estimated to account for the largest share of the market in 2023.North America is the pioneer of synthetic stem cell technology.Also, North America leads in the R of stem cell therapies globally, with the registration of the highest number of clinical trials (more than 1400) on stem cells till 2018.
1
The study involved four major activities to estimate the current market size for veterinary X-ray products.Exhaustive secondary research was done to collect information on the market, peer market, and parent market.The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.Both top-down and bottom-up approaches were employed to estimate the complete market size.Secondary Research:In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, trade directories, and databases such as D Hoovers and Bloomberg Businessweek were referred to identify and collect information for this study.According to the new market research report “Veterinary X-ray Market by Technology (Direct, Computed, Film), Type (Digital, Analog), Mobility (Fixed, Portable), Animal (Companion, Large Animal), Application (Trauma, Oncology, Dental), End User (Clinic, Hospital) – Forecast” published by MarketsandMarkets™, is projected to reach USD 872 million by 2023 from USD 640 million in 2018, at a CAGR of 6.4%.Recent Developments:– In 2018, Heska Corporation (US) formed a partnership with Pathway Vet Alliance (US).Under the terms of this agreement, Pathway plans to align its internal diagnostic portfolio with Heska, which can provide in-house operational services like point-of-care blood diagnostics, digital imaging, and allergy testing.– In 2018, Carestream Health signed a service partnership agreement with Med Imaging Healthcare, a Diagnostic Imaging equipment maintenance company.The partnership was aimed at providing wider maintenance coverage and support for Carestream customers across Scotland.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=126397675Geographically; North America accounted for the largest share of the veterinary X-ray market in 2017, followed by Europe and the Asia Pacific.
1
The high incidence of urolithiasis across the globe is a major factor driving the growth of Ureteroscopy Market.The rapidly increasing geriatric population, technological advancements in devices, and improving hospital infrastructures are the other major factors that are expected to support the growth of the flexible ureteroscopy market in the coming years.According to the new market research report “Flexible and Semi-rigid Ureteroscopy Market by Product (Flexible Ureteroscopes, Semi-rigid Ureteroscopes), Application (Urolithiasis, Urinary Stricture, Kidney Cancer), End User (ASCS, Hospitals), and Region (US, Canada, Asia, Europe) – Global Forecast” published by MarketsandMarkets™, the global semi-rigid ureteroscopy market is expected to reach USD 1,054.1 million, at a CAGR of 5.4%The Objectives of this Study are as follows:To define, describe, and forecast the flexible & semi-rigid ureteroscopy market by product type, application, end user, and regionTo forecast the revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)To identify the micromarkets with respect to drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the marketTo analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall marketRequest Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=253934795Geographically; the flexible and semi-rigid ureteroscopy market is geographically classified into North America, Europe, Asia, and the Rest of the World (RoW).North America is the largest regional market for ureteroscopes majorly due to the high prevalence of kidney stones (and the large number of surgical procedures performed for the same) and the rising healthcare expenditure in this region.Asia is expected to grow at the highest CAGR in the flexible ureteroscopy market during the forecast period.Growth in this region is mainly due to the large patient population.Some of the major players operating in ureteroscopy market are Olympus (Japan), Stryker (US), Boston Scientific (US), KARL STORZ (Switzerland), Richard Wolf (Germany), ELMED Medical Systems (Turkey), Rocamed (France), Maxer Endoscopy (Germany), ProSurg (US), and Vimex Endoscopy (Poland).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=253934795Market Segmentation in Detailed:Flexible ureteroscopes are expected to account for the largest share of the market in 2018By type of product, the flexible & semi-rigid ureteroscopes market is further segmented into flexible and semi-rigid ureteroscopes.The flexible ureteroscopes segment is expected to account for the largest share in 2018.
1
The growth of Viral Clearance Market is primarily driven by factors such as the growth in the pharmaceutical and biotechnology industries, increasing number of new drug launches, R investments in life science, advancements in nano-filtration technology, and high incidence and large economic burden of chronic diseases.According to the new market research report “Viral Clearance Market by Application (Recombinant Proteins, Blood, Vaccines), End User (Pharmaceutical & Biotechnology Companies, CROs), Method (Viral Removal (Chromatography, Nanofiltration), Viral Inactivation (Low pH)) – Global Forecast” published by MarketsandMarkets™, is expected to reach USD 724.5 million, at a CAGR of 21.7% during the forecast period.Objectives of the Study;To define, measure, and describe the global viral clearance market by application, method, end user, and regionTo provide detailed information about the major factors influencing market growth (drivers, restraints, challenges, and opportunities)To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall marketTo analyze market opportunities for stakeholders and provide details of the competitive landscape for key playersTo forecast the size of market segments in North America, Europe, Asia Pacific, and RoWRequest Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=62681197Geographically;The North American region is expected to account for the largest share of the market in 2018.The viral clearance market in the region is driven by the presence of national institutes supporting biotechnology and life science research, growth in the pharmaceuticals industry, and the increasing number of drug approvals.The rising prevalence of diseases, growing production of monoclonal antibodies, and government support for the development of drugs are some of the key factors driving the viral clearance market in the US.In Canada, increasing pharmaceutical production is expected to boost the growth of market.However, Asia Pacific is expected to witness the highest growth during the forecast period, owing to increase in generics development and manufacturing, surge in funding for medical research and the presence of a large number of CROs to provide preclinical and clinical research services in China, government initiatives to boost the use of generic drugs, increasing aging population in Japan, rise in pharmaceutical R expenditures in India, and the growing pharmaceutical manufacturing in Singapore and Malaysia.The key players in the global viral clearance market are Wuxi Biologics (Cayman) (China), Merck KGaA (Germany), Charles River Laboratories International Inc. (US), and Texcell Inc. (France), Kedrion (Italy), Vironova Biosafety (Sweden), Clean Cells (France), BSL BIOSERVICE Scientific Laboratories Munich GmbH (Germany), and ViruSure GmbH (Austria).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=62681197Market Segmentation in Detailed:The recombinant proteins segment is expected to account for the largest share of the market in 2018On the basis of application, the global market is segmented into four categories recombinant proteins, blood and blood products, vaccines, and other applications.In 2018, the recombinant proteins segment is expected to account for the largest share of the viral clearance market owing to the high potential of recombinant proteins to treat various diseases, fewer side effects, and shorter development time as compared to small molecules.Furthermore, the regulatory requirement to demonstrate the capacity of the purification process to effectively clear infectious viruses during the manufacturing of recombinant proteins is also expected to support the growth of this market segment during the forecast period.The pharmaceutical & biotechnology companies segment is expected to account for the largest share of the market in 2018By end user, the viral clearance market is segmented into pharmaceutical & biotechnology companies, CROs, academic research institutes, and other end users.
1
The Growth in North American Radiation Protection Aprons Market is driven by the increasing safety awareness among people working in radiation-prone environments, growth in the number of trained radiologic technologists, growing number of orthopedic and spine surgeries, and the increasing prevalence of cancer.On the other hand, discomfort and pain due to the heavy weight of lead aprons is expected to hamper the growth of this market during the forecast period.According to the new market research report “North American Radiation Protection Apron Market by Type (Front Protection, Vest and Skirt, Pregnancy Lead Apron), Material (Lead Aprons, Lead-Free Apron, Light Lead Composite Apron), Country (US, Canada) – North America – Forecast” published by MarketsandMarkets™, the medical radiation protection aprons market is projected to reach USD 49 million by 2024 from USD 36 million in 2019, at a CAGR of 6.6% during the forecast period.Recent Developments:– In 2019, Infab Corporation (US) received certification from Perry Johnson Registrars, Inc., an accredited certification body, to design and develop radiation protective apparel, accessories, barriers, apron racks, and gloves.– In 2018, Infab Corporation (US) announced that it would launch its revolution premium vest and skirts with interior pockets in January 2019.– In 2018, Infab Corporation (US) expanded its revolution aprons with the latest revolution color—light blue serenity.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=124332526Geographically; the US accounted for the largest share of the North American medical radiation protection aprons market in 2018.The large share of the US can primarily be attributed to the rising incidence of cancer, growing geriatric population, and the strong presence of key players in the country.Apart from this, increasing safety awareness among people working in radiation-prone environments is also expected to drive the overall medical radiation protection aprons market in the country.Prominent players in the medical radiation protection aprons market include Infab Corporation (US), Bar·Ray Products (US), Burlington Medical LLC (US), Shielding International, Inc. (US), and AliMed, Inc. (US).Infab Corporation manufactures and markets revolution lead aprons, classic lead aprons, and dental lead aprons.The company majorly focuses on organic strategies to strengthen its position in the market.For instance, in January 2019, the company launched a revolution premium vest and skirt with interior pockets.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=124332526Market Segmentation in Detailed:Front protection aprons segment accounted for the largest share of the North American medical radiation protection aprons market in 2018.Based on type, the medical radiation protection aprons market is segmented into front protection aprons, vest and skirt aprons, and other aprons.
1
The increasing incidence and prevalence of leukemia and growing demand for leukopaks for research applications are some of the factors driving the growth of these markets.However, the high cost of therapeutic leukapheresis and cellular therapies, stringent donor recruitment criteria, and long procedural time for leukapheresis are restraining the growth of this market to a certain extent.According to the new market research report “Leukapheresis Market by Product (Devices, Filters, Columns, Disposables), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma), Application (Research, Therapeutic), End User (Hospitals, Pharma, Biotech) – Global Forecast to 2026” published by MarketsandMarkets™.The global Leukapheresis Products Market is projected to reach USD 91 million by 2026 from USD 61 million in 2021, at a CAGR of 8.4% during the forecast period.The Leukopaks Market is expected to reach USD 662 million by 2026, at a CAGR of 41.9%.Growth Driver: Increasing incidence and prevalence of leukemia;Globally, the incidence of leukemia has risen significantly.According to the American Cancer Society, in 2021, there will be an estimated 61,090 new cases of leukemia in the US.It is also estimated that there will be an estimated 23,660 deaths in 2021 due to leukemia in the US.The incidence rate of leukemia in children has increased by 1% year-on-year from 2008 to 2020.It can be inferred that the rising incidence of hyperleukocytic leukemia will drive the number of therapeutic leukapheresis procedures conducted in the coming years and, thereby, support the growth of the leukapheresis market.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=20283148Geographically; the leukapheresis and leukopaks market is segmented into North America, Europe, Asia Pacific, and Rest of the World.
A medical exoskeleton, also known as a wearable robot, is a robotic machine suite worn by humans in place of their limbs to complement, substitute, and enhance human functions.It helps in physical movements by offering increased strength and endurance.The Factors such as the increasing number of people with physical disabilities and subsequent growth in the demand for effective rehabilitation approaches; agreements and collaborations among companies and research organizations for the development of the exoskeleton technology; and increasing insurance coverage for medical exoskeletons in several countries driving the growth of the medical exoskeleton market.However, the high cost of medical exoskeletons may restrict market growth to a certain extent.According to the new market research report “Medical Exoskeleton Market by Component (Hardware (Sensor, Actuator, Control System, Power Source), Software), Type (Powered, Passive), Extremities (Lower, Upper) & Mobility (Mobile, Stationary) – Global Forecast” published by MarketsandMarkets™, is projected to reach USD 571.6 million, at a CAGR of 37.4% during the forecast period.Growth Opportunity: Introduction of soft actuators;Currently, the medical exoskeletons industry is focusing on developing soft exoskeletons (without electronic motors and heavy batteries), which augment normal muscle function in healthy individuals for commercial use.Such exoskeletons have soft actuators that can be easily driven by an off-board compressor.Soft exoskeletons are attached to the body securely and comfortably and transmit forces over the body through beneficial paths such that biologically appropriate moments are created at the joints.The use of soft actuators has led to the development of inexpensive gait-supportive exoskeletons, creating opportunities for new players in the industry.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=138546702Geographically; North America is expected to dominate the market followed by Europe.The large share of this geographical segment is attributed to the growing geriatric population, increasing demand for self-assist exoskeletons, growing number of spinal cord injuries (SCI), and the high prevalence of stroke in the region.The medical exoskeleton market includes various players.
1
The growing global prevalence of lymphedema and cancer; technological advancements in diagnostic imaging modalities; and increasing investments, funds, and grants by public-private organizations are the major factors driving the growth of this market.However, the high cost of diagnostic imaging systems, the short half-life of radio-pharmaceuticals, the limited supply of helium, and the increasing adoption of refurbished diagnostic imaging systems are expected to restrain the growth of this market.According to the new market research report “Lymphedema Diagnostics Market by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) – Global Forecasts to 2024″ published by MarketsandMarkets™, is projected to reach USD 35 million by 2024 from USD 24 million in 2019, at a CAGR of 7.4%.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=145177203Geographically; the lymphedema diagnostics therapy market is segmented into four regional segments, namely, North America, Europe, the Asia Pacific, and the Rest of the World.The large share of North America can be attributed to factors such as the easy availability and rapid adoption of technologically advanced imaging systems; high incidence/prevalence of lymphedema; and the strong, well-established healthcare systems.The market in the Asia Pacific is expected to grow at the highest rate, followed by Europe.The major players operating in the lymphedema diagnostics market are GE Healthcare (US), Philips (Netherlands), and Siemens Healthineers (Germany).Other prominent players in this market include Canon, Inc. (Japan), Shimadzu Corporation (Japan), Stryker Corporation (US), Fluoptics (France), United Imaging Healthcare Co., Ltd. (China), Hitachi, Ltd. (Japan), Esaote, SpA (Italy), Neusoft Corporation (China), Mindray Medical International, Ltd. (China), Mitaka USA, Inc. (US), Curadel, LLC (US), and ImpediMed Ltd. (Australia).GE Healthcare (US) is one of the leading players in the global market.With a wide product portfolio and strong geographic presence, the company is expected to witness significant growth in the market in the coming years.Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145177203Market Segmentation in Detailed:The lymphoscintigraphy segment accounted for the largest share of the lymphedema diagnostics market in 2018.Based on technology, segmented into lymphoscintigraphy, magnetic resonance imaging (MRI), ultrasound imaging, computed tomography (CT), X-ray lymphography, bioimpedance analysis, and near-infrared fluorescence imaging.
1
The growth of the Laboratory Gas Generators Market is primarily driven by the growing importance of analytical techniques in drug and food approval processes, rising food safety concerns, increasing adoption of laboratory gas generators owing to their various advantages over conventional gas cylinders, growing demand for hydrogen gas as an alternative to helium, and the increasing R spending in target industries.On the other hand, reluctance shown by lab users in terms of replacing conventional gas supply methods with modern laboratory gas generators and the availability of refurbished products are the major factors expected to hamper the growth of this market.According to the new market research report “Laboratory Gas Generators Market by type (Nitrogen, Hydrogen, Zero Air, Purge Gas, ToC), Application (Gas Chromatography, LC-MS), End user (Life Science Industry, Chemical & Petrochemical Industry, Food & Beverage Industry) – Global Forecast to 2026” published by MarketsandMarkets™, the global lab gas generators market is projected to reach USD 686 million by 2026 from USD 353 million in 2021, at a CAGR of 14.2% during the forecast period.GROWTH OPPORTUNITY: Opportunities in the life sciences industry;The demand for the analytical testing of cannabis for ensuring its safety before human consumption has increased in recent years, as medical cannabis is being legalized in a number of countries/states across the globe.Medical cannabis has proven effective in various medical applications, such as reducing nausea caused due to chemotherapy, stimulating appetite in AIDS patients, controlling muscular spasms in multiple sclerosis patients, and reducing intraocular pressure in patients with glaucoma.Australia (2016), Canada (2015), South Korea (2018), Portugal (2001), the UK (2006), Germany (2017), Italy (2013), the Netherlands (2003), and Brazil (2017) have all legalized the use of medical cannabis in recent years.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=133302129Geographically; The lab gas generators market is divided into five regions, namely, North America, Europe, Asia Pacific, and Rest of the World.The large share of the North American region is mainly attributed to the high investments in R in the US and Canada, which has led to a higher demand for efficient and advanced laboratory equipment.The major players in the laboratory gas generators market are Parker Hannifin Corporation (US), PeakGas (UK), Linde plc (Ireland), Nel ASA (Norway), PerkinElmer Inc. (US), VICI DBS (US), Angstrom Advanced Inc. (US), Dürr Group (Germany), ErreDue spa (Italy), F-DGSi (France), LabTech S.r.l.(Italy).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=133302129Market Segmentation in Detailed:Nitrogen gas generators accounted for the larger share of the share of global lab gas generators market in 2020Based on type, segmented into nitrogen gas generators, hydrogen gas generators, zero air generators, purge gas generators, TOC gas generators, and other gas generators.
The Growth in the eTMF systems market can be attributed primarily to the rising adoption of eTMF systems, rising number of clinical trials, partnerships between biopharma companies & CROs, increasing funding to support clinical trials, and the growth in the R spending by pharma & biotech companies.Emerging countries are expected to provide significant opportunities for players in the Electronic Trial Master File (eTMF) Systems Market.However, budget constraints, data privacy issues, and a dearth of skilled professionals will challenge market growth in the coming yearsAccording to the new market research report “Electronic Trial Master File Systems Market by Component (Services, Software), End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations), Delivery Mode (On-Premise, Cloud-Based), and Region – Global Forecast to 2024″ published by MarketsandMarkets™, the eTMF systems market is projected to reach USD 1.8 billion by 2024 from USD 1.0 billion in 2019, at a CAGR of 12.7%.Request Research Sample Pages:https://www.marketsandmarkets.com/requestsampleNew.asp?id=94357456Geographically; divided into North America, Europe, Asia Pacific, and the Rest of the World (RoW).The North American market accounted for the largest share of the eTMF systems market in 2018, primarily due to the increasing government funding for clinical research and a large number of clinical trials.Several major global players are also based in the US, owing to which the country has become a center of innovation in the Electronic Trial Master File Systems MarketVeeva Systems (US), Oracle Corporation (US), Phlexglobal Limited (UK), TransPerfect Global Inc. (US), Aurea Software (US), LabCorp (US), ePharmaSolutions (US), Wingspan Technology, Inc. (US), MasterControl (US), SureClinical, Inc. (US), Dell EMC (US), Paragon Solutions (US), PharmaVigilant (US), Mayo Clinic (US), Database Integrations, Inc. (US), CareLex (US), Ennov (France), Forte Research (US), Freyr (US), Montrium (US), NCGS Inc. (US), SAFE-BioPharma (US), SterlingBio Inc. (US), BIOVIA Corp. (US), and arivis AG (Germany) are the key players in the eTMF systems market.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94357456Market Segmentation in Detailed:the cloud-based eTMF segment accounted for the largest share of the eTMF systems market in 2018.Based on delivery mode, the market is segmented into on-premise and cloud-based eTMF.In 2018, the cloud-based eTMF segment accounted for the largest share of the market.
The growth of Fiducial Markers Market is mainly attributed to factors such as the growing incidence of cancer, rising awareness on radiotherapy, and funding for cancer as well as fiducial marker research.In addition, the modernization of healthcare infrastructure and rising penetration of healthcare insurance in developing countries is expected to further fuel the growth of the market in the near future.According to the new market research report “Fiducial Markers Market by Product (Metal Based Markers (Gold, Gold Combination) Polymer Markers), Cancer Type (Prostate, Lung, Breast), Modality (CT, CBCT, MRI, Ultrasound), End user (Hospitals, Outpatient Facilities) – Global Forecast to 2025” published by MarketsandMarkets™, is projected to USD 123 million by 2025 from USD 95 million in 2019, at a CAGR of 4.5% during the forecast period of 2019 to 2025.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=180673710Geographically; the fiducial markers market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.North America is projected to hold the largest share of the regional market for fiducial markers in 2019.This is attributed to the expansion of the target patient population, favorable reimbursement scenario, greater accessibility to radiotherapy procedures, and the presence of major players in this region.The major players in Fiducial Markers Market include CIVCO Radiotherapy (US), IZI Medical Products (US), Boston Scientific Corporation (US), Naslund Medical AB (Sweden), and IBA (Belgium).Other players are Best Medical International, Inc. (US), Nanovi A/S (Denmark), Carbon Medical Technologies (US), Eckert & Ziegler (Germany), Innovative Oncology Solutions (US), Medtronic (Ireland), and QFIX (US).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180673710Market Segmentation in Detailed:The metal-based FMs product segment to register significant growth over the forecast periodBased on product, the fiducial markers market is classified into metal-based markers, polymer-based markers, and others.The metal-based markers segment is expected to register significant growth over the forecast period of 2019 to 2025.
The Growth in this market will majorly be driven by the high risk of musculoskeletal injuries to caregivers during manual handling of patients and the implementation of regulations to minimize manual patient handling.However, the lack of training to caregivers for the efficient operation of patient handling equipment is a key challenge in this market.According to the new market research report “Patient Lateral Transfer Market by Product (Air Assisted Transfer Device (Type (Regular Mattress, Split Legs Mattress, Half Mattress), Usage (Single Patient Use, Reusable)), Sliding Sheets, Accessories) End User (Hospitals) – Global Forecast to 2025” published by MarketsandMarkets™, is expected to reach USD 446.2 million by 2025 from USD 288.7 million in 2020, at a CAGR of 9.1% during the forecast period of 2020 to 2025.Growth Opportunities: Growing demand of home health care services;Globally, an increasing number of government regulations are being implemented for reducing the duration and cost involved in healthcare treatments.For instance, the Centers for Medicare and Medicaid Services (CMS) has implemented steps to provide incentives to healthcare providers for reducing hospitalization costs.Under this initiative, the CMS is promoting healthcare settings such as nursing homes and approaches such as home healthcare as they can provide quality care at reduced costs (as compared to the cost of hospitalization).This will eventually increase opportunity for home healthcare services in lateral transfer marketRequest Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=93948116Geographically; the patient lateral transfer market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latina America, and the Middle East and Africa.The large share of North America can primarily be attributed to the growing number of COVID-19 cases, rising prevalence of musculoskeletal disorders among caregivers, growing geriatric population, and the increasing incidence of chronic and lifestyle diseases.
1
The growth of Protein Expression Market is driven majorly by the increasing incidence of chronic diseases, growth in the geriatric population, and increasing demand for protein biologics.Emerging economies are likely to create significant growth opportunities for players in the market.However, the high cost of protein expression reagents and instruments, along with increasing consolidation and high barriers for new entrants, will challenge market growth.According to the new market research report “Protein Expression Market by Type (Escherichia Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus and Cell-free), Products (Reagents, Competent Cells, Instruments, Services), Application, End-User and Region – Global Forecast to 2025” published by MarketsandMarkets™, is projected to reach USD 4.1 billion by 2025 from USD 2.2 billion in 2020, at a CAGR of 13.2% between 2020 and 2025.Recent Developments:In 2020, Thermo Fisher Scientific Inc. acquired the biotechnology company, Qiagen (Germany).This acquisition will help Thermo Fisher Scientific to enhance its precision medicine portfolio through molecular diagnostics and improved life sciences solutions.In 2020, Merck announced plans for the construction of a new biotech development facility in Switzerland.This acquisition expanded Agilent’s presence and expertise in cell analysis and strengthened its position in the growing immune-oncology and immunotherapy areas.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=180323924Geographically; North America dominated the protein expression sector, followed by Europe.The major factors driving the growth of this market include the increasing incidence of chronic diseases, growth in the geriatric population, and increasing demand for protein biologics.The prominent players in protein expression market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Agilent Technologies, Inc. (US), Genscript Biotech Corporation (US), Takara Bio, Inc. (Japan), Bio-Rad Laboratories (US), Lonza (US), Promega Corporation (US), New England Biolabs (US), Oxford Expression Technologies Ltd. (US), and Synthetic Genomics Inc. (US).Thermo Fisher Scientific Inc. is the largest player in the market.
1
The Factors driving the growth of Biobanking Devices Market include the increasing number of genomics research activities for studying diseases; advances in biobanking and the growing trend of conserving cord blood stem cells of newborns; government & private funding to support regenerative medicine research; and the growing need for cost-effective drug discovery and development.According to the new market research report “Biobanking Market by Product and Service(Equipment, Consumables, Services, Software), Sample Type (Blood Products, Human Tissues, Cell Lines, Nucleic Acids), Application( Regenerative Medicine, Life Science, Clinical Research) – Global Forecast” published by MarketsandMarkets™, is expected to reach $2.69 billion, at a CAGR of 7.8%Regenerative medicine applications for biobanking market will drive the growth;Biobanking Devices Market plays an integral role in advancing biomedical and translational research, through the collection and preservation of biological samples, such as blood, tissues, and nucleic acids, which are then made available for use in research to discover disease-relevant biomarkers; this is further used for diagnosis, prognosis, and predicting drug responses.Growth in the number of research activities in this segment forms a major driver for the  market.The availability of government funding for regenerative medicine, stem cell therapeutics, and cell & gene therapy is supporting research activities in this segment.Apart from this, the increasing trend of cord blood banking will also aid growth of this market segment.Future prospects including advancements in orthopedic procedures with the use of stem cells are expected to further support market growth for regenerative medicine.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=594Geographically; segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW).North America is expected to dominate the biobanking market in 2017, this is attributed to factors like increasing research activities in regenerative medicine, cell and gene therapy; growing interest in personalized medicine and biomarker discovery; increasing number of biotechnology and pharmaceutical companies; and rising investments in genomics and proteomics research in the region as compared to other regions.Key players in the biobanking market include Thermo Fisher Scientific Inc. (U.S.), Tecan Group Ltd. (Switzerland), Qiagen N.V. (Germany), Hamilton Company (U.S.), Brooks Automation (U.S.), TTP Labtech Ltd (U.K.), VWR Corporation (U.S.), Promega Corporation (U.S.), Worthington Industries [(Taylor Wharton, U.S.)],  Chart Industries (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), Micronic (Netherlands).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=594Market Segmentation in Detailed:The equipment segment is expected to dominate the biobanking Devices MarketBy product and service, segmented into equipment, consumables, services, and software.
2
The Medical Camera Market growth is largely driven by the increasing number of surgical procedures, growing demand for endoscopic procedures, technological advancements, and increasing investments in endoscopy and laparoscopy facilities.However, the high cost of medical cameras is a major restraint for market growth.Product discontinuations, a shortage of trained medical professionals, and the availability of refurbished products are also major challenges limiting market growth to a certain extent.According to the new market research report “Medical Cameras Market by Camera Type (Endoscopy Cameras, Ophthalmology Cameras, Dermatology Cameras), Resolution (HD Cameras, SD Cameras), Sensor (CMOS, CCD), End-Users (Hospitals & Ambulatory Surgery Centers, Specialty Clinics) – Global Forecast to 2026” published by MarketsandMarkets™, is projected to reach USD 4.1 billion by 2026 from USD 2.9 billion in 2021, at a CAGR of 7.3% during the forecast period.GROWTH DRIVER: The increasing number of surgical procedures;An increasing number of surgical procedures require medical cameras, which has considerably grown in recent years.The growing number of surgeries can be attributed to the rapidly growing geriatric population worldwide and the increasing prevalence of chronic diseases, leading to the increasing demand for medical equipment.According to the United Nations (UN), in 2019, there were 703 million persons aged 65 years or over in the world.The senior population is estimated to double to 1.5 billion in 2050.
1
The growth in Single-cell Analysis Market is driven by technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and biopharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and the increasing incidence and prevalence of chronic and infectious diseases.However, the high cost of single-cell analysis products is expected to restrain the growth of this market to a certain extent during the forecast period.According to the new market research report “Single-cell Analysis Market by Cell Type (Human, Animal, Microbial), Product (Consumables, Instruments), Technique (Flow Cytometry, NGS, PCR, Mass Spectrometry, Microscopy), Application (Research, Medical Application), End User – Global Forecasts to 2025” published by MarketsandMarkets™, is projected to reach USD 5.6 billion by 2025 from USD 2.1 billion in 2019, at a CAGR of 17.8% during the forecast period.Recent Developments:In November 2019, QIAGEN launched QIAseq Multimodal Panels, which have been developed for consolidated targeted DNA and RNA enrichment and analyses.These panels save time and conserve samples that are of limited availability.In July 2019, QIAGEN partnered with Illumina with the aim to broaden the availability and use of NGS-based in vitro diagnostic (IVD) kits.In June 2019, Beckman Coulter acquired Cytobank, Inc. (US) to integrate Cytobank’s software into Beckman Coulter’s product portfolio to provide innovative solutions to customers.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=171955254Geographically; the global single-cell analysis market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.In 2018, North America accounted for the largest share of the market.The growth in this market can be attributed to the increasing drug development activities in the pharmaceutical and biotechnology industries, rising prevalence of chronic and infectious diseases, and an increase in stem cell research activities.Prominent players in the single-cell analysis market include Becton, Dickinson and Company (US), Danaher Corporation (US), Merck Millipore (US), QIAGEN (Netherlands), Thermo Fisher Scientific (US), General Electric Company (US), 10x Genomics (US), Promega Corporation (US), Illumina (US), Bio-Rad Laboratories (US), Fluidigm Corporation (US), Agilent Technologies (US), NanoString Technologies (US), Tecan Group (Switzerland), Sartorius AG (Germany), Luminex Corporation (US), Takara Bio (Japan), Fluxion Biosciences (US), Menarini Silicon Biosystems (Italy), and LumaCyte (US).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171955254Market Segmentation in Detailed:The consumables segment accounted for the largest share of the single-cell analysis market.Based on product, segmented into consumables (beads, microplates, reagents, assay kits, and other consumables) and instruments (flow cytometers, NGS systems, PCR instruments, spectrophotometers, microscopes, cell counters, HCS systems, microarrays, and other instruments).The consumables segment accounted for the largest market share in 2018.
The Growth in Breath Analyzer Market can primarily be attributed to factors such as alcohol and drug abuse, stringent government regulations and increasing use of breathalyzers in detecting various diseases.According to the new market research report “Breath Analyzer Market by Technology (Fuel Cell, Semicoductor Oxide Sensor, Others), End User (Law Enforcement Agencies, Enterprises, Individuals ), Application, Region (North America, Europe, APAC, RoW) – Global Forecast to 2025” published by MarketsandMarkets™, the breathalyzers analyzer market is expected to reach USD 1,167 million by 2025 from USD 524 million in 2020, at a CAGR of 17.4% during the forecast period.Growth Drivers: Growing alcohol and drug abuse;In 2018, about 10,511 people in the US died because of drunk driving.Excessive alcohol consumption leads to an increased risk of developing more than 200 diseases, including liver cirrhosis and some cancers.In US almost 30 people die every day due to driving under the influence (DUI) Also, high blood alcohol content was observed in~20% of fatally injured drivers in accidents in developed countries.The growing number of road accidents caused by drunk driving and drug abuse has increased the demand for breath analyzers, as these devices assist in monitoring the presence of different compounds and measuring the blood alcohol content in a breath sample.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=57484012Geographically; the breath analyzer market is segmented into North America, Asia-Pacific, Europe and Rest of the world(RoW).Asia Pacific is expected to register the highest CAGR during the forecast period.The major factors driving the growth of the Asia Pacific market include as growing consumption of alcohol, increasing research on the medical applications of breath analyzers, and the development of advanced breath analyzers.The prominent players in the global breath analyzer market include Drägerwerk AG & Co. KGaA (Germany), MPD, Inc (US), Lifeloc Technologies (US), BACtrack, Inc. (US), Quest Products, Inc. (US), Akers Biosciences, Inc. (US), Intoximeter, Inc. (US), AK GlobalTech Corporation (US), Alcohol Countermeasure Systems Corporation (Canada), EnviteC-Wismar GmbH (Germany), Lion Laboratories Ltd. (UK)Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=57484012Market Segmentation in Detailed:The fuel cell segment is expected to account for the largest share of the breath analzyer market in 2020Based on technology, segmented into fuel cells, semiconductor oxidesensors, and other technologies (infrared spectroscopy and chemical crystals).
1
The Factors such as the increasing diabetic population, the rising awareness of diabetes treatment and management, and favorable national health strategies are expected to drive the growth of the diabetes care devices (BRIC) market.According to the new market research report “Diabetes Care Devices Market by Type (SMBG, CGMS, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes, Mobile Apps), Patient Care Settings (Hospitals & Specialty Clinics, Self & Home Care), and Country (Brazil, Russia, India, China) – Forecast to 2025″ published by MarketsandMarkets™, the diabetes care devices (BRIC) market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period.Recent Developments;– In February 2020, Abbott (US) received US FDA approval for the use of FreeStyle Libre 14-day Flash glucose monitoring systems in hospitals.– In February 2020, Insulet signed a commercialization agreement with DexCom, Inc. (US) to allow its current and future CGM systems to connect to the former’s tubeless insulin pump system, OMNIPOD Horizon system.– In April 2020, Ypsomed (Switzerland) entered into a partnership with DexCom, Inc. (US) to integrate its mylife YpsoPump data with DexCom’s G6 CGM sensors to form a hybrid closed-loop system.– In January 2020, LifeScan (US) entered into a partnership agreement with DKSH to provide marketing, sales, regulatory services, as well as distribution and logistics for the sales of LifeScan products in the Philippines, Vietnam, Malaysia, Indonesia, Thailand, Hong Kong, and Taiwan.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=375Geographically; the China held the largest share in the diabetes care devices (BRIC) market in 2019.This dominance is due to the high population of diabetics in the country and increasing government funding for diabetes management and the diabetes care devices industry.India is expected to register the fastest growth during the forecast period, primarily due to opportunities presented by the country, especially in terms of the growing usage of mHealth (mobile health), which supports the diabetes management mobile applications segment.Key Market Players;The prominent players in the diabetes care devices market include Medtronic plc (Ireland), B. Braun (Germany), DexCom, Inc. (US), Abbott (US), F. Hoffman-La Roche Ltd. (Switzerland), Ascensia Diabetes Care Holdings AS (Switzerland), LifeScan (US), AgaMatrix Holdings LLC (US), Acon Laboratories, Inc. (US), ARKRAY USA, Inc. (US), Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Sanofi (France), Terumo Corporation (Japan), SD Biosensor, Inc. (South Korea), MicroGene Diagnostic Systems Pvt.Ltd. (India), Ypsomed (Switzerland), Dr. Morepen (India), Sinocare, Inc. (China), Bionime Corporation (Taiwan), and Rossmax International Ltd. (Taiwan).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=375Market Segmentation in Detailed:The blood glucose monitoring systems segment is estimated to dominate the diabetes care devices (BRIC) market in 2020Based on type, the diabetes care devices market has been segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications.Under the blood glucose monitoring systems segment, the test strips segment is estimated to account for the largest share in 2020.The dominance of this segment can be attributed to the frequent requirement of test strips in blood glucose monitoring systems.The self/home healthcare is projected to witness the highest CAGR in the diabetes care devices (BRIC) market during the forecast periodBased on end user, segmented into hospitals & specialty clinics and self/home healthcare.
The Artificial Cornea and Corneal Implant Market Growth is largely driven by the The growing geriatric population and the rising prevalence of eye diseases are the major drivers for the artificial cornea and corneal implants market.The increasing prevalence of eye disorders and government initiatives to control visual impairment are further boosting the market growth.According to the new market research report “Artificial Cornea and Corneal Implant Market by Type (Human Cornea, Artificial Cornea), Transplant Type (Penetrating Keratoplasty, Endothelial Keratoplasty), Disease Indication, End Users (Hospitals, Specialty Clinics & ASCs) – Global Forecast to 2026” published by MarketsandMarkets™, the global artificial cornea implant market is projected to reach USD 599 million by 2026 from USD 418 million in 2021, at a CAGR of 7.4% from 2021 to 2026.Growth Opportunity: Shortage of corneal donors;There is a significant requirement of corneal donors across the globe, as approximately 10 million people are in need of corneal transplants.The high burden of corneal blindness, coupled with a shortage of corneal donors, is expected to offer high-growth opportunities to manufacturers of corneal implants.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=182165973Geographically, the artificial cornea and corneal implant market is segmented into North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa.Asia Pacific is projected to witness highest CAGR during the forecast period of 2021–2026.The Asia Pacific forms the most lucrative region in the artificial cornea and corneal implants market, owing to the large population in countries such as China and India, rapid growth in the geriatric population, improving healthcare infrastructure, growing per capita income, and the rising focus of key market players on this region.The prominent players in this market are AJL Ophthalmic (Spain), CorneaGen Inc. (US), Addition Technology, Inc. (US), LinkoCare Life Sciences AB (Sweden), Presbia plc (Ireland), Mediphacos (Brazil), Aurolab (India), Cornea Biosciences (US), DIOPTEX GmbH (Austria), EyeYon Medical (Israel), Massachusetts Eye and Ear (US), Florida Lions Eye Bank (US), SightLife (US), Advancing Sight Network (US), San Diego Eye Bank (US) and L V Prasad Eye Institute (LVPEI, India).Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=182165973Market Segmentation in Detailed:The artificial cornea segment is projected to witness fastest growth during the forecast periodOn the basis of type, segmented into human cornea and artificial cornea.An artificial corneal transplant, also known as keratoprosthesis (KPro), enables the restoration of vision in conditions wherein the cornea and the eye surface is affected or damaged.
2
The increasing investments, funds, and grants for research on heart failure treatment; rising prevalence of cardiovascular diseases; long waiting periods for heart transplants; favorable reimbursements for heart pump devices; and increasing obesity are expected to offer growth opportunities in the market during the forecast period.According to the new market research report “Heart Pump Device Market by Product (Ventricular Assist Devices (LVAD, RVAD, BiVAD, and pVAD), Intra-aortic Balloon Pumps, TAH), Type (Extracorporeal and Implantable Pumps), Therapy (Bridge-to-transplant, Destination Therapy) – Global Forecast to 2026″ published by MarketsandMarkets™, is projected to reach USD 5.5 billion by 2026 from USD 2.1 billion in 2021, at a CAGR of 21.6% from 2021 to 2026.Growth Opportunity: Development of non-invasive, portable, and advanced fetal monitors;The heart pump devices market consists of various companies with products in the developmental phase.Companies with products in the pipeline focus on developing innovative solutions, which can accelerate the growth of the market.A similar trend is witnessed in the VAD industry, with players developing innovative products in the market.Various manufacturers in the field aim to commercialize their VADs in the market in the coming years.For instance, UK-based Calon Cardio-Technology Ltd. aims to receive the CE Mark for its MiniVAD around early 2024, by which time a US FDA Early Feasibility Study is due to have been completed.Similarly, the PERKAT RV right heart pump, manufactured by Germany-based NovaPump GmbH, is the only cardiac support that works percutaneously, pulsatile and self-expanding.With a successful round A funding, the company aims to participate in clinical trials and advance in R collaborations to accelerate the launch of its product.Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=237125725Geographically; segmented into North America, Europe, Asia Pacific, and the Rest of the World.
1
More

Top